Investing in Japan
Portuguese pharmaceuticals Hovione establishes presence in Osaka
Mar 17, 2017
Hovione, an established Portuguese pharmaceutical company, has opened a representative office in Osaka in June 2016 and now established Hovione K.K. in February 2017.
The company has been engaged in R&D and manufacturing of drug ingredients and compounds for more than 50 years since its foundation in 1959. Its strength lies in its expertise and advanced technology in areas such as inhalation development. It has expanded manufacturing sites in the US, Macau and Ireland. In Japan, Hovione distributes their Active Pharmaceutical Ingredients (API) for generic drugs to major pharmaceutical companies via sales agents, and it is also engaged in contracted development and manufacturing development as well as the particle engineering.
Hovione plans to apply for a license of Marketing Authorization Holder (MAH) and to obtain additional sales approval of its API.
For the establishment of Hovione’s base in Japan, the JETRO Invest Japan Business Support Center (IBSC) provided support such as consultation (corporate registration, labor affairs and tax matters) and invitation to Japan to assist the establishment of the base.